As permitted by the terms of Amedisys' merger agreement with Option Care Health, Amedisys entered into a confidentiality agreement with Optum on May 30, 2023. Exploratory discussions are currently being engaged in with Optum regarding the proposal.
Related Link: Why Portage Biotech Stock Is Up Today
AMED Price Action: Shares of AMED were up 14.5% at $90.97 at the time of publication, according to Benzinga Pro.
Image by svklimkin from Pixabay
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
